Repligen Appeals Ruling in Dispute with Bristol-Myers
In September, the United States District Court for the Eastern District of Michigan ruled that there was insufficient evidence for a university scientist to be named as an inventor on these patents. The lawsuit was filed by Repligen and the University of Michigan.
The dispute concerns key patents regarding a compound now in testing for rheumatoid arthritis. It dates back to a now-defunct research collaboration between...
To view the full article, register now.